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Carbonated hydroxyapatite (CHAp) and -tricalcium phosphate (-TCP) have been employed
for  decades as constituents of scaffolds for bone regeneration because they chemically
resemble bone mineral. In this study, the feasibility to manufacture CHAp/-TCP scaffolds
by  pseudomorphic transformation of casted blocks of gypsum was investigated.
The transformation was carried out by immersing the precursor gypsum block in 1 M
(NH4)2HPO4/1.33 M NH4OH solution with liquid/solid ratio of 10 mL/g and autoclaving at
120 ◦C and 203 kPa (2 atm) for 3 h at least. Neither shape nor dimensions signiﬁcantly
changed during transformation. The composition of scaffolds treated for 3 h was 70 wt.%
CHAp and 30 wt.% -TCP, and their compressive and diametral compressive strengths were
6.5  ± 0.7 and 5.3 ± 0.7 MPa, respectively. By increasing the time of treatment to 6 h, the
composition of the scaffold enriched in -TCP (60 wt.% CHAp and 40 wt.% -TCP) but its
compressive and diametral compressive strengths were not signiﬁcantly affected (6.7 ± 0.9
and  5.4 ± 0.6 MPa, respectively).
On the basis of the results obtained, it was concluded that this route is a good approach
to  the manufacturing of biphasic (CHAp/-TCP) scaffolds from previously shaped pieces ofgypsum.
©  2016 SECV. Published by Elsevier Espan˜a, S.L.U. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).∗ Corresponding author.
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366-3175/© 2016 SECV. Published by Elsevier Espan˜a, S.L.U. This is an open access article under the CC BY-NC-ND license (http://
reativecommons.org/licenses/by-nc-nd/4.0/).
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Fabricación  de  andamios  de  fosfato  de  calcio  mediante  transformación
pseudomórﬁca  del  yeso
Palabras clave:
Hidroxiapatita carbonatada
-Fosfato tricálcico
Yeso
Pseudomorﬁsmo
Implante óseo
r  e  s  u  m  e  n
La hidroxiapatita carbonatada (CHAp) y el -fosfato tricálcico (-TCP) han sido utilizados
durante décadas como constituyentes de los andamios para regeneración ósea, debido a su
semejanza química con la sustancia mineral del hueso. En este trabajo se investigó la viabili-
dad  de fabricación de andamios de CHAp/-TCP mediante transformación pseudomórﬁca
de bloques de yeso previamente moldeados. La transformación se realizó sumergiendo el
bloque precursor de yeso en una disolución 1 M (NH4)2HPO4/1,33 M NH4OH en proporción
líquido/sólido de 10 mL/g, y autoclavando a 120 ◦C y 203 kPa (2 atm) durante al menos 3 h. Ni
la  forma ni las dimensiones de la pieza cambiaron signiﬁcativamente durante la transforma-
ción. La composición de los andamios obtenidos con 3 h de tratamiento fue 70% m/m  CHAp
y  30% m/m -TCP, y sus resistencias a la compresión y a la compresión diametral fueron de
6,5  ± 0,7 y 5,3 ± 0,7 MPa, respectivamente. Incrementando el tiempo de tratamiento a 6 h, la
composición del andamio se enriqueció en -TCP (60% m/m CHAp y 40% m/m -TCP), pero su
resistencia no varió signiﬁcativamente (resistencia a la compresión 6,7 ± 0,9 MPa y resisten-
cia  a la compresión diametral 5,4 ± 0,6 MPa). Sobre la base de los resultados obtenidos se
concluyó que esta ruta resulta adecuada para la fabricación de andamios bifásicos a partir
de  piezas de yeso previamente moldeadas.
© 2016 SECV. Publicado por Elsevier Espan˜a, S.L.U. Este es un artı´culo Open Access bajo
la  CC BY-NC-ND licencia (http://creativecommons.org/licencias/by-nc-nd/4.0/).Introduction
Modern approach to bone regeneration is based on the use
of scaffolds and osteoinductive factors. Scaffolds are tem-
porary tridimensional and macroporous structures made of
biocompatible and resorbable materials which are intended
to attract and support the colonization of mesenchymal stem
cells and their differentiation into osteoproductive cells. Ide-
ally, the scaffold resorption rate should match the rate of new
bone growth [1].
The use of additive manufacturing (AM) processes for the
fabrication of 3D scaffolds for bone regeneration has received
great attention in the last decade [2]. Among the several
AM techniques available 3D-Printing (3-DP) on powder layer
is particularly interesting because of its simplicity and low
cost [3].
Some of the available commercial systems employ a pow-
der mainly consisting in Plaster of Paris (CaSO4·(1/2)H2O, CSH)
and an aqueous binder ink. During printing, the setting of
powder takes place according to the hydration reaction of Eq.
(1) and, after removing unreacted powder; solid pieces made
of gypsum (CaSO4·2H2O, CSD) are obtained.
CaSO4 · 12H2O(s) + 1
1
2
H2O → CaSO4 · 2H2O(s) (1)
CSD was the ﬁrst ceramic material used for bone repairing. It
was successfully employed by Dreesmann [4] in 1892 for ﬁlling
bone cavities of different etiologies (tuberculosis, osteomyeli-
tis, enchondroma) in 8 patients. Seventy years later Peltier
demonstrated that CSD implants in dogs were biocompatible
and totally resorbed within a few weeks to a few months, but
they failed to stimulate osteogenesis [5]. Nevertheless, CSDhas been clinically used to date to ﬁll bone defects, alone
or in combinations with osteoinductive factors or antibiotics,
because of its low cost, availability, easy handling, injectability
and moldability [6].
The in vivo resorption rate of CSD is considerably higher
than the rate of growth of new bone. This is the main con-
cern for using CSD scaffolds for bone regeneration procedures
in clinics, especially when large defects are involved. Instead,
materials with lower resorption rates, such as the less soluble
apatite-like calcium phosphates, are generally preferred for
manufacturing scaffolds for bone engineering [7–14].
Pseudomorphing is the phenomenon by which one
mineral is replaced by another while preserving the macro-
scopic shape, but changing the chemical composition and
microstructure. It occurs in nature as consequence of weath-
ering during millions of years [15]. At the beginning of the
seventies, coral (CaCO3, calcite) was pseudomorphically trans-
formed into HAp by hydrothermal reaction with aqueous
(NH4)2HPO4 at 180–350 ◦C and 103 MPa for 12–48 h [16]. Since
then, a lot of coralline HAp-based materials became commer-
cially available and has been successfully applied for bone
regeneration procedures in clinics.
More recently, the pseudomorphical transformation of
CSD monoliths into HAp by treatment in alkaline phosphate
solutions have been reported [17–22]. According to the pub-
lished results, previous dehydration of CSD to CSH is required
in order to strengthen the scaffold and to speed off the
hydrothermal reaction. Minor amounts of more  acidic cal-
cium phosphates (CaHPO4·2H2O, DCPD or CaHPO4, DCP) were
formed along with HAp.The purpose of this study was to investigate the man-
ufacturing of calcium phosphate scaffolds by direct hydro-
thermal transformation of CSD monoliths, without previous
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[25]. The test was conducted on disks (6 mm h; 12 mm Ø) byhis work.
ehydration to CSH, and avoiding formation of acidic calcium
hosphates.
xperimental
reparation  of  CSD  scaffolds  and  probes
SH (Gesso Diamante – Orto, IGE, Araripina, PE, Brazil) was
ixed with water at W/P  ratio of 0.50 mL/g to prepare scaffolds
nd probes with the shapes and sizes of Fig. 1.
The holes in prismatic scaffolds (Fig. 1a) were made during
olding. For this a silicone mold with inserts for 1 mm Ø stain-
ess steel pins was employed. The slurry made from CSH and
ater (W/P = 0.5 mL/g) was casted in the assembled mold with
nserted pins. When the initial setting was reached, pins were
arefully removed and the piece was let setting for 1 h. Then,
ieces were demolded and let dry in air to constant weight,
nd used for X-ray diffraction, SEM and EDS analysis.
Solid cylinders (Fig. 1b) and disks (Fig. 1c) (with not holes)
ere casted in a similar way, and used for strength and bioac-
ivity tests.
ydrothermal  treatment  with  ammonium  phosphate
olution
roups of 5 pieces were placed into glass ﬂasks with
NH4)2HPO4/NH4OH (Vetec, Sao Paulo, Brazil) solution
1.00 M/1.33 M,  pH 9.8) with a L/S ratio of 10 mL/g. The
asks were partially stoppered and autoclaved (Autoclave
ertical, CS, Prismatec, SP, Brazil) at temperature of 120 ◦C
nd pressure of 2 atm (203 kPa) for periods of time between á m i c a y v i d r i o 5 5 (2 0 1 6) 105–113 107
1 and 6 h. Then, autoclaved probes were washed with water
and oven dried at 75 ◦C for 24 h.
Examination  by  XRD  analysis
X-ray diffraction (Shimadzu 7000, Japan) was used to ana-
lyze the qualitative and quantitative phase composition of
the specimens before and after hydrothermal treatment. The
X-ray diffraction patterns were obtained on powdered sam-
ples using CuK ( = 1.5418 A˚) radiation, and anode operation
voltage and current of 40 kV and 30 mA,  respectively. The 2
interval between 10◦ and 40◦ was recorded at sweep rate of
0.2◦/min. X’Pert HighScore Plus (PANalytical, The Netherlands)
software was used for qualitative phase analysis and GSAS-II
software [23] was employed to perform the quantitative phase
analysis by the Rietveld method [24]. The crystal structures of
the ICSD database with codes 27875 for CSD, 73263 for CSH,
26205 for HAp and 97500 for -tricalcium phosphate (-TCP,
-Ca3(PO4)2) were used in Rietveld reﬁning. The typical val-
ues obtained for the weighted proﬁle R-factor during structural
and compositional reﬁning were in the range 11.3–12.2.
FTIR  spectroscopy
Attenuated Total Reﬂectance infrared spectra of powdered
samples were collected in a Spectrum 400 FTIR/FTNIR spec-
trometer (Perkin Elmer, USA). Spectra were scanned in the
range from 4000 to 650 cm−1 with resolution of 4 cm−1.
SEM  observation
External and fracture surfaces of untreated and treated with
ammonium phosphate solution specimens were observed by a
Phenom ProX (Phenom-World B.V., The Netherlands) desktop
scanning electron microscope (SEM) coupled with an X-Ray
Energy Dispersive Spectroscopy (EDS) system. Samples were
examined as obtained, without any metal coating.
Measurement  of  compressive  and  diametral  compressive
strength
Compressive and diametral compressive strength tests were
carried out on cylinders (12 mm h; 6 mm Ø; n = 5) and disks
(6 mm h; 12 mm Ø; n = 5) Fig. 1), respectively, before and after
being treated for 6 h. Tests were carried out in an Instron 3366
Dual Column testing machine (Instron Corp., USA) provided
with 500 N and 10 kN load cells, for diametral and axial tests,
respectively, and a plate displacement rate of 0.5 mm/min.
In  vitro  bioactivity
The in vitro bioactivity of selected samples, understood as the
ability to form an apatite layer on their surfaces in vitro, was
assessed as indicated in ISO 23317:2012 – Implants for surgery
– In vitro evaluation for apatite-forming ability of implant materialsincubating in SBF at 36.5 ± 1.5 ◦C for 1, 3 and 7 days. The ratio
of apparent surface of solid to SBF volume was 10 cm2/mL  and
ﬂasks with samples soaked in SBF remained static during the
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Before After
Fig. 2 – Scaffolds before (as casted) and after hydrothermal treatment for 6 h in diammonium hydrogen phosphate solution.
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Fig. 3 – Experimental X-ray diffraction patterns of the CSDwhole incubation period. The presence of the apatite layer was
veriﬁed by SEM.
Results  and  discussion
The scaffolds employed in this work (Fig. 1a) bore nine crossing
holes distributed on their largest face to provide macroporos-
ity, and to minimize the diffusion path of the reagent solution
into the material.
The casted scaffolds were stiff enough to stand handling
and water immersion without distinguishable disintegration.
The appearance of the scaffolds, before (as casted) and
after hydrothermal treatment, is displayed in Fig. 2. Neither
shape nor dimensions signiﬁcantly changed after hydro-
thermal treating during different periods of time (1–6 h).
Only CSH peaks were observed in the X-ray diffraction pat-
tern of the starting Plaster of Paris. On the other hand, CSD was
the only crystalline phase found in casted scaffolds (Fig. 3, 0 h).
During hydrothermal treating several changes in phase
composition occurred which are displayed in the X-ray diffrac-
tion patterns of Fig. 3.
After 1 h of treatment only diffraction peaks corresponding
to CSD, HAp and -TCP were observed (Fig. 3, 1 h). Dehydra-
tion of CSD to CSH, as represented in Eq. (2), is to be expected
since the CSD↔CSH transition temperature at 1 atm, is 97 ◦C
[26], and the reaction mixture was submitted to temperature
of 120 ◦C and vapor pressure of 2 atm.
CaSO4 · 2H2O(s)
120 ◦C, 2 atm−→ CaSO4 · 12H2O(s) + 1
1
2
H2O(g) (2)
The appearance of HAp peaks is also predictable, and accord-
ing with previous reports can be exempliﬁed by Eq. (3) [18].
10CaSO4 · 0.5H2O(s) + 6(NH4)2HPO4(aq) + 8NH4OH(aq)
→ Ca10(PO4)6(OH)2(s) + 10(NH4)2SO4(aq) + 11H2O (3)Formation of -TCP, was evidenced by the peaks at angles (2)
of 21.87◦, 27.76◦ and 31.02◦, which match the diffractions with
Miller indexes of (0 2 4) (I/Io = 0.16, d = 4.06 A˚), (2 1 4) (I/Io = 0.55,
d = 3.21) and (0 2 10) (I/Io = 1, d = 2.88 A˚) (Powder Diffraction Filescaffolds after different times of hydrothermal treatment.
Code 9-169). No previous reports were found on the crys-
tallization of -TCP by hydrothermal treatment of CSD in
ammonium phosphate solution. However, direct formation of
-TCP from precipitated amorphous calcium phosphate (ACP)
by hydrothermal synthesis in presence of carboxylic acids has
been described by Toyama et al. [27]. According to their results
ACP was transformed into DCP by hydrothermal treatment at
160 ◦C. By increasing temperature to 200 ◦C a mixture of DCP
and -TCP was obtained, and a further increase to 220 ◦C ren-
dered -TCP alone.The formation of DCP and HAp in the core and the crust
of CSD monoliths, respectively, during hydrothermal treat-
ment at 120 ◦C in unbuffered (NH4)2HPO4 solution, has been
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reviously described [28], and we can hypothesize that in the
uffered solution employed in this work, DCP is formed in the
ore as an intermediate that continues reacting to -TCP as
xempliﬁed in Eqs. (4) and (5).
aSO4 · 0.5H2O(s) + (NH4)2HPO4(aq)
→ CaHPO4(s) + (NH4)2SO4(aq) (4)
CaHPO4(s) + NH4OH(aq)
→ Ca3(PO4)2(s) + NH4H2PO4(aq) + H2O (5)vidences for direct HAp hydrolysis to -TCP at 90 ◦C and pH
ower than 7 have also been published [29]. According to this, it
s also possible another route for -TCP formation represented
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in Eq. (6).
3Ca10(PO4)6(OH)2(s) + 2NH4H2PO4(aq)
→ 10Ca3(PO4)2(s) + 2NH4OH(aq) + 2H2O (6)
The phase composition for the material obtained after 1 h of
treatment, as estimated by the Rietveld reﬁnement method,
was 39 wt.% CSD, 45 wt.% HAp and 16 wt.% -TCP.
The same phases were observed for the period of 1.5 h
(Fig. 3, 1.5 h).
After 3 h of treatment hydrothermal peaks corresponding
to CSH completely disappeared and only HAp and -TCP were
detected (Fig. 3, 3 h). The estimated composition was 73 wt.%
HAp and 27 wt.% -TCP.
The picture change little at the end of 6 h of treatment
(Fig. 3, 6 h) when 63 wt.% HAp and 37 wt.% -TCP were
obtained.
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The reader should notice that in most of the previous
reports the formula Ca10(PO4)5(OH)2 have employed to repre-
sent the apatite resulting from the hydrothermal reaction of
Eq. (3). However, Suzuki et al. found that carbonate apatite
was obtained by hydrothermal treatment of gypsum with
(NH4)2HPO4 solution, even without intentional addition of any
source of CO32− ion [18]. They concluded that the alkaline
character of the reaction media was responsible for absorp-
tion of CO2 from air which was incorporated to the structure
of the apatite partially substituting PO43–, resulting in type B
carbonate HAp (CHAp) [18].
Fig. 4 shows the ATR-FTIR spectra of the starting powder
of CSH, the CSD scaffolds immediately after setting (0 h), and
after hydrothermal treatment for 3 h.
Bands corresponding to vibration stretching of the
bond O–H of crystal water in the wavenumber region of
3600–3200 cm−1, and 3600–3000 cm−1 for the starting CSH
powder and set scaffolds before any treatment (0 h). The single
band at 1622 cm−1 and the doublet at 1683 and 1622 cm−1 are
characteristic of bending vibration of crystal water in CSH and
CSD, respectively. Typical strong and broad bands of stretch-
ing vibration of the S–O bonds in SO42− ion were observed in
the region between 1200 and 950 cm−1 while bending vibra-
tions appeared at 656 cm−1 and 666 cm−1 for CSH and CSD
(0 h) [30]. After the hydrothermal treatment for 3 h the bands
characteristic for vibrations of SO42− group and crystal H2O
in CSD were replaced by vibrational bands corresponding to
vibrations characteristic of free OH, absorbed H2O, PO43− and
CO32−. The acute band at 3572 cm−1 is characteristic of the
stretching vibration of the structural OH group in HAp and the
other bands in the region of 3200–3000 cm−1 and the band at
1643 cm−1 can be assigned to the stretching and bending vibra-
tions of OH in loosely bonded water, respectively. Asymmetric
(3) and symmetric (1) stretching vibrations of P-O bond in
PO43− are the responsible for the bands at 1000–1100 cm−1
and 961 cm−1, respectively [31,32]. The bands characteristic of
asymmetric stretching vibration (3) and out-of-plane bending
of the C-O bond in CO32− group in carbonate HAp (CHAp) are
observed at 1448 cm−1 and 875 cm−1, respectively [33]. The 3
band at 1450 cm−1 can considered as a ﬁngerprint for type B
CHAp [34], that is, part of the PO43− ions in the crystal structure
was replaced for CO32− ions.
Thus, the product of the hydrothermal treatment of CSD
scaffolds was a mixture of type B CHAp and -TCP.
Structural and compositional modiﬁcations experienced by
the CSD scaffolds after 1, 3 and 6 h of treatment are displayed
in Fig. 5. The fracture surface of CSD scaffolds before treat-
ment consisted of needle- and plate-like crystals typical of
CSD [18], being more  abundant the ﬁrst ones. The EDS anal-
ysis conﬁrmed that only Ca, S, and O occurred (Fig. 4, 1 h) as
corresponds for CSD.
In the SEM micrograph of the specimen treated for 1 h
an increase in porosity could be noticed with regard to the
untreated scaffold. Its structure consisted of ﬁne needle-like
crystals of HAp [18] together with prismatic crystals typical of
-TCP [35]. The appearance of Ca and P peaks, and the diminu-
tion of S peak in the EDS spectrum conﬁrmed the formation
of Ca,P-containing phases at the expense of CSH (Fig. 4, 1 h).
By increasing the transformation time to 3 and 6 h, little
change was observed in morphology of the scaffolds. However,(NH4)2HPO4/1.33 M NH4OH.
the EDS spectra showed continued decreasing of the intensity
of the S peak and increasing of Ca and P peaks. A decrease of
the intensity ratio of Ca and P peaks could be noticed as well,
from 3 to 6 h, caused by the decrease in HAp/-TCP abundance
ratio, as already evidenced from the results of quantitative
phase analysis.
The above results showed that biphasic calcium phosphate
scaffolds consisting of CHAp and -TCP, were obtained after
3 h of treatment by the procedure described above.
The CHAp:-TCP ratio can be increased by using longer
periods of treatment. For example, hydrothermal treatment
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or 3 h yielded scaffolds with CHAp:-TCP ratio of 70:30,
pproximately; while after 6 h of treatment CHAp:-TCP ratio
as 60:40. Controlling the CO3-HAp:-TCP ratio allows tuning
he resorption rate of the scaffolds, in similar way as in
ommercial biphasic calcium phosphate ceramics (BCP) con-
tituted of HAp and -TCP [36].
Probes of CSD treated as described before for 3 h exhibited
ompressive strength (CS) of 6.5 ± 0.7 MPa.  During compres-
ive testing, upon reaching the limit load, the test probes were
rushed instead of breaking fragilely. In order to indirectly
ssess the tensile strength, diametral compressive (DCS) test
as also carried out. In this test a tensile stress is generated
ormally to the loading direction on a vertical disk [37]. A
CS of 5.3 ± 0.7 MPa was found for probes submitted to hydro-
hermal treatment for 3 h. This value was signiﬁcantly greater
han the value of 2.8 MPa reported for CSD monoliths treated
ith (NH4)3PO4 at 100 ◦C for 24 h [19].
The formation of a surface layer of biological carbonate-
patite when implanted in vivo, is a necessary condition for
onding of bioactive materials to living bone tissue. In vivo
ioactive materials are also able to form a surface layer of
patite after being immersed in a synthetic solution that
mitates the composition of blood plasma (SBF), at body tem-
erature, for different periods of time, and these are the basis h of treatment and immersed in SBF at 36.5 ◦C for 0, 1, 3,
 in SBF.
for a common in vitro method to determine bioactivity of mate-
rials [25,38]. Thus, in vivo bioactivity was determined for the
CHAp/-TCP scaffold obtained by 3 h of treatment. The SEM
micrographs of the sample surface after soaking for 0, 1, 3
and 7 days are shown in Fig. 6. After 1 day of immersion in
SBF it was detected a change in the surface morphology of
the sample, characterized by the appearance of globular crys-
talline aggregates. The globular aggregates grew and reached
conﬂuence after 3 days of immersion, completely covering
the surface of the sample, and this morphology was main-
tained after 7 days of immersion. The same structure has been
described for the apatite-layer formed by bioactive materials
when soaked in SBF [38]. The EDS analysis of the surface of
samples revealed the presence of Ca, P and O, before soak-
ing (0 d) and after 3 days of soaking in SBF (3 d), but the Ca/P
peak intensities increased with soaking. Bearing in mind that
before soaking there is a mixture of approximately 70 wt.%
CHAp and 30 wt.% -TCP, the increasing of the Ca/P ratio by
soaking points out that globular aggregates consist of apatite,
and that the scaffold obtained is bioactive in vitro.According to authors’ best knowledge, obtaining a mixture
of CHAp and -TCP by hydrothermal treatment of gypsum
monoliths has not been previously described. While the for-
mation of HAp, DCP or DCPD, and mixtures of HAp and DCP
 d e c
r112  b o l e t í n d e l a s o c i e d a d e s p a ñ o l a
(or DCPD) has been previously reported [22,28,39], the forma-
tion of -TCP by hydrothermal reaction of CSD in solutions
of ammonium phosphate was no observed. All researchers
who  have addressed the transformation of CSD into calcium
phosphates have employed plain solutions of (NH4)2HPO4,
regardless of the acidiﬁcation of the reaction medium that
occurs, as illustrated in Eqs. (3)–(5), during the transforma-
tion of gypsum. This can result in the formation of acidic
phases such as DCP or DCPD. The consequences of the acidi-
ﬁcation of the medium can be most evident in the core of the
monolith, where removal of exhausted medium and arrival
of fresh one can be seriously hindered [28,40]. The reaction
medium employed in this work was a solution containing 1 M
(NH4)2HPO4 and 1.33 NH4OH with high buffer capacity which
ensures the maintenance of a pH higher than 9 along the com-
plete reaction. However, the mechanism conducting to the
formation of -TCP deserves further research.
Conclusions
Scaffolds containing two crystalline phases, CHAp and -TCP,
where obtained by the method proposed in this work, using
previously casted CSD monoliths as starting material. Com-
plete transformation of the precursor was achieved after 3 h of
reaction. The ratio between the constituent phases (CHAp and
-TCP) can be varied adjusting the reaction time: The larger
the reaction time, the richest is the scaffold in -TCP. Nei-
ther shape nor dimensions were signiﬁcantly affected during
processing, and the resulting biphasic scaffolds were strong
enough to stand handling and immersion in water. The scaf-
folds developed a surface apatite layer after soaking 3 days in
SBF which suggest they are bioactive in vivo.
The processing route proposed is effective for manufactur-
ing biphasic (CHAp/-TCP) scaffolds from previously shaped
pieces of gypsum.
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